Clinical trial
Preoperative Identification of Response to Neoadjuvant Chemoradiotherapy for Esophageal Cancer (PRIOR)
NCT02125448 is registered in ClinicalTrials.gov with Gert Meijer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preoperative Identification of Response to Neoadjuvant Chemoradiotherapy for Esophageal Cancer (PRIOR)
- Lead sponsor
- Gert Meijer
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2013
- Completion date
- November 30, 2016
- Enrollment
- 30 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
esophageal cancer